Big savings achieved with smarter use of nitroprusside, isoproterenol
Yet most eligible patients do not participate
Daylong course in Cleveland on Nov. 3, 2017
Beyond the headlines on CANTOS, REVEAL, COMPASS
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Keeping ahead of the curve to improve care, convenience
Celecoxib has least impact, followed by naproxen and ibuprofen
ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes
Post hoc analysis suggests more heart failure patients might benefit
A sampling of the year’s notable stats
Agreement expands access to complex heart care for contracted employers’ pediatric beneficiaries
Advertisement
Advertisement